期刊
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 72, 期 2, 页码 144-154出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2009.01.003
关键词
Myeloid growth factors; Neutropenic fever; Prophylactic antibiotics
Chemotherapy-induced myelosuppression is a major complication of chemotherapy regimens used to treat solid tumors and lymphomas. Myelosuppression is frequently accompanied by neutropenic fever and other complications and threatens the ability to maintain chemotherapy dose intensity. Two prophylaxis strategies have been evaluated to mitigate the infectious complications of myelosuppression: myeloid growth factors and antibiotic. Clinical trials and meta-analyses of trial data indicate substantial benefit to these agents in selected patients. Each type of prophylaxis has advantages and disadvantages. Additional studies are needed to optimize how these are employed in clinical practice. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据